JPRN-UMIN000005963已完成未知
Case-control study of the effect of HMG-CoA reductases on subarachnoid hemorrhage - SAH-Statin Study
Department of Neurosurgery, Shiga University of Medical Science0 个研究点目标入组 400 人开始时间: 2011年7月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 400
研究概览
简要总结
The risk of subarachnoid hemorrhage may be reduced with the medication of specific drugs.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Cerebral aneurysms due to trauma, dissection, infection, autoimmune diseases, hereditary diseases are excluded.
研究者
相似试验
已完成
1 期
A Randomized, Double-Blind, Placebo-Controlled Trial of Simvastatin on Subarachnoid Hemorrhage-Induced VasospasmDelayed VasospasmSubarachnoid HemorrhageNCT00235963Brigham and Women's Hospital104
已完成
3 期
Japan Statin Treatment Against Recurrent Stroke (J-STARS)Ischemic StrokeNCT00221104Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan1,578
尚未招募
2 期
Magnesium Treating Subarachnoid Hemorrhage VasospasmCerebral VasospasmSubarachnoid Hemorrhage, AneurysmalNCT04613960General Committee of Teaching Hospitals and Institutes, Egypt200
已完成
3 期
Treatment With HMG-COA Reductase Inhibitor of Growth and Bone Abnormalities in Children With Noonan SyndromeNoonan SyndromeNCT02713945University Hospital, Toulouse53
已完成
不适用
Change in the incidence of subarachnoid hemorrhage by verification of annual registratiosubarachnoid hemorrhageJPRN-UMIN000034241Department of Neurosurgery, Graduate School of Biomedical and Health Sciences Hiroshima University30,000